Postop time | Treatment group | Achieved 6/9 or better vision—ie, <0.2 logMAR | Proportion ratio: Phako/ECCE (95% confidence limits) | Fisher's exact test p value | ||||
---|---|---|---|---|---|---|---|---|
No (%) | ||||||||
Unaided visual acuity | ||||||||
Week 3 | Phako | 80/244 (33) | 2.89 (1.93–4.33) | <0.001 | ||||
ECCE | 26/229 (11) | |||||||
Week 6 | Phako | 85/237 (36) | 2.37 (1.67–3.38) | <0.001 | ||||
ECCE | 34/225 (15) | |||||||
Month 3 | Phako | 83/237 (35) | 1.84 (1.33–2.55) | <0.001 | ||||
ECCE | 42/221 (19) | |||||||
Month 6 | Phako | 89/235 (38) | 1.83 (1.34–2.48) | <0.001 | ||||
ECCE | 45/217 (21) | |||||||
Month 12 | Phako | 87/224 (39) | 1.99 (1.45–2.73) | <0.001 | ||||
ECCE | 42/215 (20) | |||||||
With spectacle correction | ||||||||
Week 3 | Phako | 213/244 (87) | 1.28 (1.16–1.42) | <0.001 | ||||
ECCE | 156/229 (68) | |||||||
Week 6 | Phako | 213/237 (90) | 1.15 (1.06–1.25) | 0.001 | ||||
ECCE | 176/225 (78) | |||||||
Month 3 | Phako | 220/237 (93) | 1.16 (1.08–1.25) | <0.001 | ||||
ECCE | 177/221 (80) | |||||||
Month 6 | Phako | 217/235 (92) | 1.07 (1.00–1.14) | 0.046 | ||||
ECCE | 187/217 (86) | |||||||
Month 12 | Phako | 204/224 (91) | 1.06 (0.99–1.14) | 0.076 | ||||
ECCE | 184/215 (86) |